Dennis E. Marshall - 28 Dec 2022 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Director
Signature
/s/ John R. Browning, Attorney-in-fact
Issuer symbol
BLGO
Transactions as of
28 Dec 2022
Net transactions value
$0
Form type
4
Filing time
29 Dec 2022, 19:42:59 UTC
Previous filing
05 Oct 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option to Purchase Common Stock Award $0 +37,500 +1.1% $0.000000 3,590,354 28 Dec 2022 Common stock 37,500 $0.1689 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was granted to Reporting Person to replace an option previously issued to compensate Reporting Person for services to the Issuer, which expired, unexercised, due to a discrepancy between the original exercise price and current stock price of the Issuer, pursuant to plan adopted by the Issuer's Compensation Committee and Board of Directors.
F2 Reflects the December 28, 2022, expiration of an option to purchase 75,000 shares.